'Clotting risk' with contraceptives (Press Association, 10 May 2012)

Congratulations to new Fellows of the Academy of Medical Sciences

New drug controls growth hormone (MedPage Today, 10 May 2012)

11 May 2012

Novartis have announced the results of their phase III trial examining the use of pasireotide for the treatment of acromegaly. The study was presented at the joint International Congress of Endocrinology/European Congress of Endocrinology.

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read